Dongjun Dai
Ningbo University
35 Papers
139 Citations
Dongjun Dai is an academic researcher from Ningbo University. The author has contributed to research in topics: DNA methylation & Internal medicine. The author has an hindex of 14, co-authored 29 publications.
Chat about Author
Papers
Association of BDNF and BCHE with Alzheimer's disease: Meta-analysis based on 56 genetic case-control studies of 12,563 cases and 12,622 controls.
Huihui Ji,Dongjun Dai,Yunliang Wang,Danjie Jiang,Xingyu Zhou,Peipei Lin,Xiaosui Ji,Jinfeng Li,Yuzheng Zhang,Honglei Yin,Rongrong Chen,Lina Zhang,Mingqing Xu,Shiwei Duan,Qinwen Wang +14 more
TL;DR: The current meta-analysis suggests that BDNF C270T is a risk factor for AD in Asians under a dominant model, and has been, to the best of the authors' knowledge, the most comprehensive meta- analysis of BDNF Val66Met, BDNFC270T and BCHE-K to date.
Association of CDKN2BAS Polymorphism rs4977574 with Coronary Heart Disease: A Case-Control Study and a Meta-Analysis
Yi Fei Huang,Huadan Ye,Qingxiao Hong,Xuting Xu,Danjie Jiang,Limin Xu,Dongjun Dai,Jie Sun,Xiang Gao,Shiwei Duan +9 more
TL;DR: A strong association between a non-protein coding single nucleotide polymorphism (SNP) rs4977574 of CDKN2BAS gene and coronary heart disease (CHD) was observed and was observed in females and males.
43
Meta-analysis of low density lipoprotein receptor (LDLR) rs2228671 polymorphism and coronary heart disease.
Huadan Ye,Qianlei Zhao,Yi Huang,Lingyan Wang,Haibo Liu,Chunming Wang,Dongjun Dai,Leiting Xu,Meng Ye,Shiwei Duan +9 more
TL;DR: Meta-analysis has established LDLR rs2228671 as a protective factor of CHD in Europeans and the lack of association in Chinese reflects an ethnic difference of this genetic variant between Chinese and European populations.
Elevated methylation of OPRM1 and OPRL1 genes in Alzheimer's disease
Chunshuang Xu,Guili Liu,Huihui Ji,Chen Weihua,Dongjun Dai,Zhongming Chen,Dongsheng Zhou,Lei Xu,Haochang Hu,Wei Cui,Lan Chang,Qin Zha,Liping Li,Shiwei Duan,Qinwen Wang +14 more
TL;DR: The results of the present study suggested that opioid receptor genes may be used as potential methylation biomarkers for the diagnosis of AD.
OPRK1 promoter hypermethylation increases the risk of Alzheimer's disease.
Huihui Ji,Yunliang Wang,Guili Liu,Xuting Xu,Dongjun Dai,Zhongming Chen,Dongsheng Zhou,Xiaohui Zhou,Liyuan Han,Ying Li,Renjie Zhuo,Qingxiao Hong,Liting Jiang,Xiaonan Zhang,Yu Liu,Lei Xu,Lan Chang,Jinfeng Li,Pengyuan An,Shiwei Duan,Qinwen Wang +20 more
TL;DR: The results suggested that O PRK1 promoter hypermethylation might increase the risk of AD through its regulation on the gene expression of OPRK1.
30